Internal Medicine, Hematology & Oncology · Asheville, NC
NPI
1669764064
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
551 Brevard Rd
Asheville, NC, 28806
Phone (828) 212-7021
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.8M
129,905 services
Medicare patients, 2024
866
Average age 74
Drug cost, 2024
$10.0M
2,270 prescriptions
Company payments, 2025
$2,166
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brent M Skiver was code J9025 (injection, azacitidine, 1 mg), 17,300 times for 14 patients. In total Brent M Skiver billed 129,905 services in 165 codes, and Medicare paid $2.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9025 Injection, azacitidine, 1 mg | Office | 17,300 | 14 | $0.28 | $4,865 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 16,020 | 21 | $39.44 | $632K |
| J0185 Injection, aprepitant, 1 mg | Office | 7,410 | 29 | $1.34 | $9,952 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 5,800 | 17 | $44.62 | $259K |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 2,330 | 13 | $31.30 | $73K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,300 | 21 | $15.68 | $36K |
| J9041 Injection, bortezomib, 0.1 mg | Office | 1,610 | 13 | $1.40 | $2,249 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,490 | 11 | $35.00 | $52K |
| 85025 Blood Count | Office | 1,379 | 583 | $7.59 | $10K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,291 | 58 | $0.09 | $117 |
| J0897 Injection, denosumab, 1 mg | Office | 1,260 | 11 | $20.55 | $26K |
| 36415 Venipuncture Blood Collection | Office | 1,201 | 569 | $8.62 | $10K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 760 | 22 | $0.07 | $54.74 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 740 | 39 | $0.71 | $526 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 637 | 105 | $70.45 | $45K |
By year: 2022 $1.4M for 93,535 services; 2023 $1.7M for 120,370 services; 2024 $2.8M for 129,905 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,379 | 583 | $7.59 | $10K |
| 36415 Venipuncture Blood Collection | 1,201 | 569 | $8.62 | $10K |
| 85045 Blood Count | 88 | 69 | $3.91 | $344 |
| 81002 Clinical Chemistry | 39 | 21 | $3.41 | $133 |
Medicare prescription drug claims, 2024
In 2024, the drug Brent M Skiver prescribed most often to Medicare patients was Acyclovir, with 190 prescriptions and refills. In total Brent M Skiver wrote 2,270 Medicare prescriptions that cost $10.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 190 | 290 | 47 | $2,207 |
| Revlimid Lenalidomide | 151 | 151 | 26 | $2.5M |
| Eliquis Apixaban | 108 | 134 | 25 | $76K |
| Dexamethasone Generic | 67 | 85 | 34 | $1,798 |
| Imbruvica Ibrutinib | 60 | 60 | Under 11 | $964K |
| Imatinib Mesylate Generic | 57 | 57 | Under 11 | $8,995 |
| Hydroxyurea Generic | 55 | 132 | 18 | $1,147 |
| Lenalidomide Generic | 53 | 53 | 13 | $775K |
| Ondansetron Hcl Generic | 52 | 52 | 18 | $626 |
| Levofloxacin Generic | 51 | 59 | 28 | $903 |
| Gabapentin Generic | 51 | 57 | 11 | $315 |
| Anastrozole Generic | 51 | 145 | 15 | $749 |
| Calquence Acalabrutinib Maleate | 49 | 49 | Under 11 | $607K |
| Allopurinol Generic | 46 | 68 | 20 | $247 |
| Brukinsa Zanubrutinib | 46 | 46 | Under 11 | $523K |
Brand drugs: - claims; generic drugs: 1,458 claims; opioid claims: 65.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brent M Skiver $2,166 ($2,166 in general payments such as food, travel and fees) from 29 companies. The largest payer was Caris MPI, Inc. with $1,111.
| Company | Payments | Amount |
|---|---|---|
| Caris MPI, Inc. | 2 | $1,111 |
| Pfizer Inc. PFE | 7 | $135 |
| BeOne Medicines USA, Inc. ONC | 5 | $104 |
| GlaxoSmithKline, LLC. GSK | 4 | $95.71 |
| Janssen Biotech, Inc. JNJ | 2 | $68.17 |
| Daiichi Sankyo Inc. 4568.T | 3 | $66.71 |
| Lilly USA, LLC LLY | 3 | $61.82 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $43.96 |
| Abbvie Inc. ABBV | 2 | $35.04 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $32.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.